Medifast (MED) Non-Current Assets (2010 - 2026)

Medifast's Non-Current Assets history runs 17 years deep, the most recent figure standing at $49.4 million for Q1 2026.

• Quarterly Non-Current Assets fell 25.68% year-over-year to $49.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $219.0 million (down 19.43% YoY) and the FY2025 annual result came in at $46.3 million, down 33.69% from the prior year.
• Non-Current Assets was $49.4 million for Q1 2026 at Medifast, up from $46.3 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $97.2 million in Q2 2022 and bottomed at $46.3 million in Q4 2025.
• A 5-year average of $77.7 million and a median of $83.2 million in 2024 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2022 — Non-Current Assets soared 118.21% — and 2025, when it sank 33.69%.
• Medifast's Non-Current Assets stood at $93.4 million in 2022, then decreased by 8.08% to $85.9 million in 2023, then dropped by 18.71% to $69.8 million in 2024, then sank by 33.69% to $46.3 million in 2025, then climbed by 6.75% to $49.4 million in 2026.
• Business Quant data shows MED's Non-Current Assets at $49.4 million in Q1 2026, $46.3 million in Q4 2025, and $60.4 million in Q3 2025.